China · Clinical Trials startup
China · NovoCodex
NovoCodex is a biopharmaceuticals company that specalizes in the business of genetic engineering, and cell culture.
Funding reportedLast round: Series A
What company datasets say NovoCodex raised
Funding, as reported
Reported in all400Min the source's currency
Rounds1
Last roundSeries A
Last round dateMar 2021
Investors listed3
Clinical Trials in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put NovoCodex in front of investors. Or tell us what we have wrong.